Stevanato group secures €200 million in financing from bnl bnp paribas, cassa depositi e prestiti, and banco bpm to fund ongoing capex investments in italy and the u.s.

Piombino dese, italy--(business wire)--stevanato group s.p.a. (nyse: stvn), a global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it has secured €200 million in financing through agreements with bnl bnp paribas, cassa depositi e prestiti (cdp), and banco bpm. these fundings are intended to support the company's ongoing capital expenditure projects in cisterna di latina (italy) and f.
STVN Ratings Summary
STVN Quant Ranking